Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical de...
Its market capitalization was $1,515 as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
No profile data available.